Close mobile menu×
Close mobile menu

Claire S. Riley, MD

Board Certifications: 
Neurology
Accepting New Patients
Profile Headshot

Appointments

Phone Appointments

New and Existing Patients: 

Connect Patient Portal

For existing patients, login to make an appointment, view documentation or contact your care provider.

Credentials & Experience

Board Certifications

  • Neurology

Clinical Expertise

  • Multiple Sclerosis
  • Neuromyelitis Optica
  • Optic Neuritis
  • Susac's Syndrome
  • Transverse Myelitis

Specialties

Education & Training

  • Columbia University College of Physicians and Surgeons
  • Residency: Harlem Hospital Center
  • Residency: NewYork-Presbyterian Hospital/Columbia University Medical Center
  • Fellowship: NewYork-Presbyterian Hospital/Columbia University Medical Center

About Claire Riley

Dr. Claire Riley earned an undergraduate degree from Dartmouth College and a medical degree from Vagelos College of Physicians and Surgeons (VP&S). She completed an internship in internal medicine and her residency in neurology at Columbia University Irving Medical Center. In addition, she completed a two-year clinical fellowship in the Columbia University Multiple Sclerosis Center in 2010. Dr. Riley is board certified in neurology by the American Board of Psychiatry and Neurology.

Dr. Riley returned to Columbia University as Director of the Multiple Sclerosis Center in January 2012. She was previously an attending neurologist and assistant professor in the Yale MS Center in New Haven, CT. Dr. Riley regularly teaches medical students, residents and fellows in the MS clinic. She is also an investigator in clinical trials related to multiple sclerosis.

Columbia University's Multiple Sclerosis Center is a premier treatment and research facility for individuals living with multiple sclerosis. Our center remains dedicated to providing the most advanced diagnostic and therapeutic care available to our patients.

Academic Titles

  • Assistant Professor of Neurology

Administrative Positions

  • Clinical Director, Multiple Sclerosis Center

Hospital Affiliations

  • NewYork-Presbyterian / Columbia University Irving Medical Center

Gender

  • Female

Insurance Accepted

Aetna

  • EPO
  • HMO
  • Medicare Managed Care
  • NYP Employee Plan
  • NY Signature
  • POS
  • PPO
  • Signature Administrators
  • Student Health

AgeWell

  • Medicare Managed Care
  • Special Needs Plan

Capital District Physician Health Plan

  • Capital District Physician Health Plan

Cigna

  • EPO
  • Great West
  • HMO
  • POS
  • PPO

Emblem/GHI

  • Medicare Managed Care
  • PPO

Emblem/HIP

  • ConnectiCare
  • EPO
  • Essential Plan
  • HMO
  • Medicaid Managed Care
  • Medicare Managed Care
  • POS
  • PPO
  • Select Care (Exchange)
  • Vytra

Empire Blue Cross Blue Shield

  • EPO
  • Medicare Managed Care
  • PPO

Local 1199

  • Local 1199

MagnaCare

  • MagnaCare

Multiplan

  • Multiplan

MVP Health Care

  • Child/Family Health Plus
  • Essential Plan
  • HMO
  • Medicaid Managed Care

Oxford Health Plans

  • Freedom
  • Liberty

UnitedHealthcare

  • Columbia University Employee Plan
  • HMO
  • Medicaid (Community Plan)
  • Medicare Managed Care
  • POS
  • PPO

*Please contact the provider’s office directly to verify that your particular insurance is accepted.

Contact & Locations

1
710 West 168th Street
New York, New York 10032
Primary

Research

Grants

A PRAGMATIC TRIAL TO EVALUATE THE INTERMEDIATE-TERM EFFECTS OF EARLY, AGGRESSIVE VERSUS ESCALATION THERAPY IN PEOPLE WITH MULTIPLE SCLEROSIS (Private)

Sep 26 2018 - Feb 1 2024

AN OPEN-LABEL SINGLE ARM STUDY TO EVALUATE THE EFFECTIVENESS AD SAFETY OF OCRELIZUMAB IN PATIENTS WITH EARLY STAGE RELAPSING REMITTING MULTIPLE SCLEROSIS (P&S Industry Clinical Trial)

Jun 23 2017 - Jun 23 2022

EFFECT OF MD1003 IN PROGRESSIVE MULTIPLE SCLEROSIS: A RANDOMIZED DOUBLE BLIND PLACEBO CONTROLLED STUDY (P&S Industry Clinical Trial)

May 31 2017 - May 31 2022

AN OPEN-LABEL STUDY TO EVALUATE THE EFFECTIVENESS AND SAFETY OF OCRELIZUMAB IN PATIENTS WITH RELAPSING REMITTING MULTIPLE SCLEROSIS WHO HAVE HAD A SUBOPTIMAL RESPONSE TO AN ADEQUATE COURSE OF DISEASE-MODIFYING TREATMENT (P&S Industry Clinical Trial)

Jul 15 2016 - Jul 15 2021

ASPIRIN BEFORE EXERCISE: ANTIPYRETIC PRETREATMENT TO REDUCE EXERCISE-INDUCED OVERHEATING AND EXHAUSTION IN RRMS PATIENTS (Federal Gov)

Apr 1 2019 - Mar 31 2021

COLLABORATIVE INTERNATIONAL RESEARCH IN CLINICAL AND LONGITUDINAL EXPERIENCE FOR NEUROMYELITIS OPTICA STUDIES (CIRCLES) (Private)

Jul 1 2018 - Jun 30 2020

SOCIAL WORKER SALARY SUPPORT AT COLUMBIA MS CENTER (Private)

Jan 1 2019 - Dec 31 2019

PHYSICAL TELEREHABILITATION IN PATIENTS WITH MULTIPLE SCLEROSIS WITH SIGNIFICANT MOBILITY IMPAIRMENT (Federal Gov)

Sep 29 2016 - Sep 29 2019

NATIONAL MULTIPLE SCLEROSIS TISSUE REPOSITORY NETWORK (Private)

Jan 1 2019 - Jun 30 2019

A MULTICENTER, OPEN-LABEL, 12-MONTH OBSERVATIONAL STUDY EVALUATING THE CLINICAL EFFECTIVENESS AND IMPACT ON PATIENT-REPORTED OUTCOMES OF ORAL TECFIDERA (DIMETHYL FUMARATE) DELAYED-RELEASE CAPS IN PTS WITH RELAPSING FORMS OF MS (P&S Industry Clinical Trial)

Nov 22 2013 - Nov 22 2018

SPINAL MUSCULAR ATROPHY (SMA) BIOMARKERS IN THE IMMEDIATE POSTNATAL PERIOD OF DEVELOPMENT NN101 (Federal Gov)

Sep 30 2011 - Aug 31 2018

MRI PREDICTORS OF DISEASE AND DISABILITY PROGRESSION IN AFRICAN AMERICANS WITH MULTIPLE SCLEROSIS (Federal Gov)

Sep 30 2017 - Jul 31 2018

COLLABORATIVE INTERNATIONAL RESEARCH IN CLINICAL AND LONGITUDINAL EXPERIENCE FOR NEUROMYELITIS OPTICA (NMO) STUDIES (CIRCLES) (Private)

Apr 1 2016 - Mar 31 2018

PROTECTION AGAINST COGNITIVE DECLINE IN MS: LONGITUDINAL INVESTIGATION OF RESERVE (Federal Gov)

Jul 11 2016 - Apr 30 2017

IMPROVING ACCESS TO MULTIPLE SCLEROSIS SUBSPECIALTY CARE IN WASHINGTON HEIGHTS NEIGHBORHOOD OF MANHATTAN (Private)

Jan 1 2016 - Dec 31 2016

BRAIN TEMPERATURE IN MULTIPLE SCLEROSIS: ADVANCING OUR UNDERSTANDING AND TREATMENT OF FATIGUE (Private)

Oct 1 2015 - Sep 30 2016

RESERVE AGAINST PHYSICAL DISABILITY IN PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS (Private)

Sep 1 2014 - Aug 31 2015

IMPROVING ACCESS TO MULTIPLE SCLEROSIS SUBSPECIALTY CARE IN WASHINGTON HEIGHTS NEIGHBORHOOD OF MANHATTAN (Private)

Jan 1 2014 - Dec 31 2014

RESTING STATE FUNCTIONAL CONNECTIVITY AS A PREDICT (Private)

Aug 1 2014 - Nov 30 2014

A RANDOMIZED CONTROLLED TRIAL OF VITAMIN D SUPPLEMENTATION IN MULTIPLE SCLEROSIS (Private)

Jul 15 2012 - Mar 31 2014

DEVELOPMENT OF A TEST FOR AUTOANTIBODIES IN SUSAC SYNDROME (Private)

Jan 1 2012 - Dec 31 2013

IMPROVING ACCESS TO MULTIPLE SCLEROSIS SUBSPECIALTY CARE IN WASHINGTON HEIGHTS NEIGHBORHOOD OF MANHA (Private)

Jan 1 2013 - Dec 31 2013